sever
acut
respiratori
syndromecoronaviru
sarscov
etiolog
agent
sar
viru
unknown
us
sar
epidem
concert
effort
research
promptli
elucid
genet
code
genom
sarscov
polyadenyl
rna
genom
organ
typic
coronavirus
characterist
gene
order
spike
envelop
e
membran
nucleocapsid
n
short
untransl
region
termini
sequenc
inform
rapid
pcrbase
molecular
diagnost
test
sarscov
infect
design
besid
offer
molecular
diagnosi
quantit
measur
viral
load
pcrbase
technolog
also
exploit
amplifi
genom
fragment
sarscov
sequenc
analysi
high
sensit
specif
pcr
made
genom
sequenc
analysi
possibl
even
uncultur
clinic
specimen
unlik
convent
microbiolog
method
pcrbase
technolog
may
requir
viral
cultur
could
introduc
culturederiv
artifact
genom
sequenc
specif
pcr
primer
select
amplifi
sarscov
sequenc
background
nucleic
acid
sequenc
contribut
patient
microb
moreov
pcrbase
method
versatil
term
type
clinic
specimen
hand
success
analyz
sarscov
genom
directli
uncultur
sampl
serum
nasopharyng
aspir
stool
obviat
concern
poor
even
unsuccess
viral
cultur
preciou
clinic
specimen
risk
handl
largevolum
hazard
viral
cultur
could
also
avoid
genom
sequenc
variat
observ
sarscov
obtain
differ
patient
epidem
base
sequenc
variat
isol
typifi
two
group
isol
obtain
patient
epidemiolog
link
metropol
hotel
hong
kong
exampl
seven
sequenc
variat
distinguish
isol
link
metropol
hotel
isol
link
hotel
case
cluster
tabl
among
four
variat
nucleotid
posit
accord
sequenc
genbank
access
suggest
chines
sar
molecular
epidemiolog
consortium
part
haplotyp
configur
mark
differ
phase
triphas
sar
epidem
guangdong
provinc
china
carri
haplotyp
g
c
c
typifi
middl
phase
notabl
haplotyp
observ
one
earliest
confirm
case
sar
hong
kong
document
even
report
hotel
case
cluster
carri
haplotyp
typifi
late
phase
mark
hotel
case
cluster
spread
viru
mani
part
world
genom
sequenc
variat
sarscov
also
reveal
rout
infect
within
commun
across
citi
instanc
compar
isol
two
mutat
first
appear
isol
genbank
access
number
obtain
patient
involv
amoy
garden
outbreak
hong
kong
later
two
genet
fingerprint
appear
complet
sequenc
taiwanes
isol
interestingli
toward
end
epidem
anoth
type
fingerprint
found
pcrbase
method
variant
sarscov
delet
report
cluster
patient
seem
epidemiolog
relat
case
part
document
outbreak
north
district
hospit
hong
kong
illustr
sequenc
variat
among
differ
isol
remark
epidemiolog
correl
thu
pcr
amplif
follow
sequenc
power
tool
trace
rout
transmiss
sequenc
inform
may
provid
object
support
epidemiolog
investig
moreov
event
sar
reemerg
one
could
quickli
gain
import
insight
origin
evolut
statu
sarscov
simpli
sequenc
critic
sequenc
variat
genom
exemplifi
howev
extract
wealth
inform
limit
primari
clinic
sar
specimen
need
sensit
effici
protocol
effici
amplifi
fragment
sarscov
genom
analysi
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
absolut
ethanol
superscript
iii
rnase
h
revers
transcriptas
invitrogen
carlsbad
ca
random
hexam
appli
biosystem
foster
citi
ca
firststrand
synthesi
buffer
mm
trishcl
ph
mm
mm
invitrogen
rnasin
rnase
inhibitor
promega
madison
wi
dntp
invitrogen
dithiothreitol
dtt
rnasefre
water
promega
advantag
cdna
polymeras
mix
buffer
bd
bioscienc
clontech
palo
alto
ca
dntppcr
primersdistil
water
genom
sequenc
involv
pcr
amplif
produc
numer
copi
target
dna
cycl
sequenc
requir
pipet
manipul
pcr
product
step
could
easili
contamin
laboratori
environ
amplifi
product
contamin
problem
would
affect
interpret
sequenc
result
advers
affect
perform
diagnost
test
design
detect
viral
sequenc
henc
extrem
care
taken
avoid
contamin
suggest
follow
precaut
perform
rna
extract
pcr
amplif
genom
sequenc
differ
laboratori
least
separ
dedic
compart
laboratorytransf
reagent
sampl
aerosolresist
pipet
tipsprepar
pcr
reagent
master
mix
hood
dedic
purpos
set
clean
glove
dedic
lab
gown
worn
area
illumin
hood
ultraviolet
useani
step
involv
handl
cdna
primari
secondari
pcr
product
includ
addit
dna
templat
assembl
pcr
electrophoresi
cycl
sequenc
perform
dedic
area
far
away
pcr
reagent
separ
lab
gown
set
glove
worn
areadiscard
pipet
tip
contact
dna
extrem
care
use
doubl
bag
disposalinclud
multipl
neg
pcr
control
amplif
monitor
environment
contamin
prepar
avl
lysi
buffer
wash
buffer
accord
manufactur
qiagen
instruct
see
note
biosafeti
level
contain
laboratori
lyse
ml
vol
viral
cultur
ad
ml
vol
avl
buffer
mix
incub
room
temperatur
min
direct
clinic
sampl
eg
serum
nasopharyng
aspir
stool
also
use
see
note
add
ml
absolut
ethanol
mixtur
pulsevortex
sload
mixtur
qiaamp
spin
column
wash
column
accord
manufactur
instructionsadd
rnasefre
water
onto
membran
incub
min
room
temperatur
centrifug
spin
column
min
small
aliquot
extract
viral
rna
yield
realtim
quantit
reversetranscript
rt
pcr
see
note
store
extract
rna
prewarm
two
thermocycl
block
heat
lid
respectivelymix
pmol
random
hexam
rna
tube
denatur
min
see
note
period
assembl
reaction
mix
anoth
tube
ice
accord
tabl
use
superscript
iii
rnase
h
revers
transcriptas
see
note
denatur
snapcool
rnaprim
mixtur
ice
min
briefli
spin
tube
add
reaction
mix
prepar
step
rnaprim
mixtur
make
total
reaction
volum
mix
pipet
gentli
downimmedi
transfer
tube
ice
prewarm
thermocycl
block
incub
prewarm
thermocycl
block
tube
prewarm
thermocycl
block
incubationheat
inactiv
minadd
u
rnase
h
incub
min
remov
rna
complementari
cdnadilut
product
two
fivefold
distil
water
store
use
insid
hood
dedic
set
pcr
assembl
pcr
master
mix
reaction
accord
tabl
cdna
polymeras
mix
see
note
genom
sequenc
sarscov
final
reaction
volum
add
aliquot
pcr
micropl
add
pmol
forward
pcrf
revers
pcrr
seri
primer
reaction
amplifi
overlap
amplicon
cover
whole
sarscov
genom
see
note
primer
sequenc
shown
tabl
area
separ
hood
dedic
pcr
add
dilut
reversetranscrib
productscomm
pcr
thermocycl
initi
denatur
min
cycl
min
min
min
final
extens
min
insid
hood
dedic
set
pcr
assembl
pcr
master
mix
reaction
accord
tabl
final
reaction
volum
add
aliquot
new
pcr
microplateadd
pmol
forward
pcrf
revers
bseqr
seri
primer
seminest
pcr
reaction
primer
sequenc
shown
tabl
area
separ
hood
dedic
pcr
add
correspond
primari
pcr
productcomm
pcr
thermocycl
initi
denatur
min
cycl
min
min
min
final
extens
minelectrophores
secondari
pcr
product
agaros
gel
verifi
success
pcr
amplif
estim
amount
pcr
product
comparison
dna
marker
product
singl
band
use
sequenc
perform
sequenc
reaction
base
dideoxi
dye
termin
method
accord
manufactur
instruct
separ
hood
dedic
pcr
assembl
cycl
sequenc
reaction
aseqf
bseqf
aseqr
bseqr
seri
oligonucleotid
sequenc
primer
amplicon
ng
secondari
pcr
product
sequenc
templat
see
note
commenc
cycl
sequenc
reaction
thermocyclerpurifi
extens
product
either
spin
column
purif
ethanol
precipit
mix
resuspend
dna
formamid
solut
accord
manufactur
instructionsdenatur
purifi
extens
product
min
snapcool
ice
load
onto
autom
capillari
dna
sequenc
inject
edit
align
compar
sequenc
use
strain
genbank
access
number
refer
softwar
design
purpos
exampl
seqscap
see
note
resequ
region
reveal
nucleotid
substitut
use
combin
differ
primer
set
ensur
qualiti
sequenc
data
see
note
rna
extract
carrier
poli
rna
ad
lysi
buffer
increas
yield
pcr
primer
specif
sarscov
genom
subsequ
amplif
would
affect
howev
one
want
perform
rapid
amplif
cdna
end
race
similar
clone
oper
depend
oligo
dt
prime
poli
tail
viral
rna
carrier
poli
rna
avoidedour
previou
studi
shown
two
round
pcr
even
direct
clinic
sampl
sequenc
obviat
need
viral
cultur
may
pose
health
hazard
handl
properli
also
minim
possibl
gener
viral
mutant
cultur
howev
direct
clinic
sampl
high
viral
titer
sensit
pcr
amplif
requiredyield
viral
rna
determin
quantit
rtpcr
spectrophotometr
determin
prone
error
result
low
rna
quantiti
interfer
carrier
poli
rna
contribut
rna
presenta
prolong
denatur
step
use
remov
secondari
rna
structur
sarscov
genom
imped
reversetranscript
use
random
hexam
ensur
even
represent
whole
rna
genom
allow
sequenc
inform
obtain
limit
amount
viral
rnaw
recommend
use
revers
transcriptas
increas
thermal
stabil
facilit
reversetranscript
higher
temperatur
normal
unfold
secondari
rna
structur
thu
produc
longer
cdna
higher
yieldsw
recommend
simultan
use
two
differ
dna
polymeras
pcr
amplif
exampl
cdna
polymeras
mix
use
contain
dna
polymeras
second
dna
polymeras
proofread
activ
inclus
minor
amount
proofread
polymeras
result
error
rate
significantli
lower
taq
alon
advantag
obviou
one
concern
genom
sequenc
variat
differ
viral
strain
use
twopolymeras
system
also
increas
effici
yield
henc
sensit
import
viral
titer
suboptimalth
carryov
unus
pcr
primer
sequenc
reaction
would
lead
poor
sequenc
result
like
sequenc
primer
unus
pcr
primer
would
also
bind
nonspecif
sequenc
templat
cycl
sequenc
reaction
henc
gener
noisi
sequenc
trace
overshadow
intend
trace
purif
pcr
product
thu
usual
recommend
prior
use
sequenc
templat
howev
method
laborintens
pose
extra
contamin
risk
involv
addit
step
open
handl
pcr
product
notabl
suggest
optim
pcr
protocol
direct
sequenc
pcr
product
without
pcr
product
purif
low
pcr
primer
concentr
optim
number
cycl
pcr
primer
consum
end
pcr
furthermor
nest
sequenc
primer
select
extend
specif
pcr
product
cycl
sequenc
reaction
would
suppress
nonspecif
pcr
product
extens
combin
effect
neat
sequenc
traceth
amount
pcr
product
use
sequenc
reaction
must
optim
care
differ
sequenc
system
although
pcr
product
input
usual
give
higher
signal
intens
may
also
give
shorter
read
length
oversatur
signalsth
pcr
primer
target
amplicon
overlap
along
sarscov
genom
sequenc
primer
design
way
sequenc
mask
pcr
primer
bind
site
sequenc
primer
peak
one
amplicon
reliabl
back
homolog
sequenc
overlap
ampliconw
advoc
scrutin
effort
valid
genom
sequenc
variat
resequenc
region
differ
combin
primer
sequenc
chemistri
variat
seen
singl
viral
isol
could
potenti
result
sequenc
artifact
consid
genom
sequenc
variat
share
least
two
sarscov
isol
